Medical device

• US 6,259,948 B1
• Filed: 11/13/1998
• Issued: 07/10/2001
• Est. Priority Date: 11/13/1998
• Status: Expired due to Term

• Current Assignee: CAIS, INCORPORATED
• Original Assignee: Pacesetter Incorporated (Abbott Laboratories Incorporated)
• Inventors: Myers, Mark R., Florio, Joseph J., Levine, Paul A.
• Primary Examiner(s): Getzow, Scott M.
• Application Number:
  US09/191,166
• Time in Patent Office: 970 Days
• Field of Search: 607/9, 607/17, 607/18, 607/19
• US Class Current: 607/9
• CPC Class Codes: A61N 1/36542 controlled by body motion, e.g. acceleration
• CPC Class Codes: A61N 1/368 comprising more than one electrode co-operating with different heart regions A61N1/3622, A61N1/3627 take precedence

Abstract

A device in the form of a cardiac pacemaker for treating a malfunctioning heart, in which the intrinsic heart rate information is combined with secondary sensor variance information to select an appropriate therapy for the patient. The cardiac pacemaker has operational capability in the sleep mode and includes a hysteresis function. The hysteresis function is disabled during operation in the sleep mode and a pacing therapy is selected based upon the intrinsic heart rate and sleep mode operation.

Claims

1. An implantable medical device for stimulating a patient'"'"'s heart through at least one electrode implanted in electrical contact with the patient'"'"'s heart, the medical device comprising:

a pulse generator electrically coupled to the electrode and configured to generate stimulation pulses to thereby stimulate the patient'"'"'s heart at a controlled rate;

a detection circuit electrically coupled to the electrode and configured to receive signals from the patient'"'"'s heart indicating intrinsic heart beats;

a sensor circuit for monitoring a physiologic variable of the patient and for determining whether the patient is in one of at least two physiologic states, wherein a first physiologic state corresponds to the patient being inactive and a second physiologic state corresponds to the patient being active; and

a processor, coupled to the pulse generator, the detection circuit, and the sensor circuit, for increasing the controlled rate in response to the absence of an intrinsic heart beat when the sensor circuit determines that the patient is in the active physiologic state.

2. The medical device of claim 1 wherein the sensor circuit measures the activity level of the patient.

3. The medical device of claim 1 wherein:

the sensor circuit periodically measures a physiologic value and periodically determines the difference between sequential physiologic values to generate a sensor variance signal; and

wherein

the sensor circuit determines the physiologic state of the patient according to the sensor variance signal.

4. The medical device of claim 3 wherein the physiologic states are determined according to at least one threshold value which divides the sensor variance signal values into at least two sets of values corresponding to physiologic states.

5. The medical device of claim 1 wherein the sensor circuit measures the body position of the patient.

6. The medical device of claim 1 wherein the sensor circuit measure the oxygen content of the patient'"'"'s blood.

7. The medical device of claim 1 wherein the controlled stimulation rate is determined according to an escape interval and the controlled stimulation rate is increased by decreasing the escape interval.

8. A method for detecting vasovagal syncope and providing treatment to a patient'"'"'s heart by applying stimulation pulses at a controlled stimulation rate through at least one electrode implanted in electrical contact with the patient'"'"'s heart, the method comprising:

monitoring a physiologic sensor to determine a current physiologic value;

determining a sensor variance signal in response to the difference between consecutively monitored physiologic values;

determining a physiologic mode in response to the variance signal, wherein the physiologic mode includes indicating that that the patient is in an inactive or an active state;

monitoring for intrinsic heart beats; and

increasing the controlled stimulation rate in response to the absence of an intrinsic heart beat when the physiologic mode indicates the patient being in an active state and thereby treating vasovagal syncope.

9. The method of claim 8 wherein the determining the physiologic mode is determined according to a threshold value which divides the sensor variance signal values into at least two sets of values corresponding to physiologic states.

10. The method of claim 8 wherein the physiologic sensor measures the activity level of the patient to determine the physiologic mode.

11. The method of claim 8 wherein the physiologic sensor measures the oxygen content of the patient'"'"'s blood to determine the physiologic mode.

12. The method of claim 8 wherein the physiologic sensor measures the patient'"'"'s body position to determine the physiologic mode.

13. The method of claim 8 wherein the controlled stimulation rate is determined according to an escape interval and the controlled stimulation rate is increased by decreasing the escape interval.